$1.01 Earnings Per Share Expected for HB Fuller Co (FUL) This Quarter

Share on StockTwits

Analysts expect HB Fuller Co (NYSE:FUL) to post earnings per share (EPS) of $1.01 for the current fiscal quarter, according to Zacks Investment Research. Four analysts have issued estimates for HB Fuller’s earnings, with the lowest EPS estimate coming in at $0.94 and the highest estimate coming in at $1.05. HB Fuller reported earnings per share of $0.75 during the same quarter last year, which would suggest a positive year-over-year growth rate of 34.7%. The firm is scheduled to report its next earnings report on Tuesday, January 22nd.

On average, analysts expect that HB Fuller will report full year earnings of $3.11 per share for the current year, with EPS estimates ranging from $3.05 to $3.15. For the next financial year, analysts expect that the firm will post earnings of $3.85 per share, with EPS estimates ranging from $3.60 to $4.03. Zacks Investment Research’s EPS averages are a mean average based on a survey of analysts that cover HB Fuller.

HB Fuller (NYSE:FUL) last issued its quarterly earnings results on Wednesday, September 26th. The specialty chemicals company reported $0.86 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.90 by ($0.04). HB Fuller had a net margin of 4.14% and a return on equity of 13.41%. The company had revenue of $770.11 million for the quarter, compared to analyst estimates of $784.75 million.

Several analysts have recently commented on the stock. Zacks Investment Research downgraded shares of HB Fuller from a “buy” rating to a “hold” rating in a report on Monday, September 3rd. ValuEngine downgraded shares of HB Fuller from a “hold” rating to a “sell” rating in a report on Friday, September 28th. Robert W. Baird dropped their price objective on shares of HB Fuller from $60.00 to $55.00 and set a “neutral” rating on the stock in a report on Friday, September 28th. Deutsche Bank dropped their price objective on shares of HB Fuller from $62.00 to $60.00 and set a “buy” rating on the stock in a report on Friday, September 28th. Finally, Berenberg Bank assumed coverage on shares of HB Fuller in a report on Thursday, July 12th. They issued a “buy” rating and a $65.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and five have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $61.00.

In related news, VP Traci L. Jensen sold 4,508 shares of the stock in a transaction on Thursday, August 9th. The shares were sold at an average price of $57.45, for a total transaction of $258,984.60. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 3.46% of the stock is owned by corporate insiders.

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Piedmont Investment Advisors LLC boosted its holdings in HB Fuller by 9.1% during the second quarter. Piedmont Investment Advisors LLC now owns 11,783 shares of the specialty chemicals company’s stock worth $633,000 after buying an additional 983 shares in the last quarter. D.A. Davidson & CO. boosted its holdings in HB Fuller by 20.0% during the second quarter. D.A. Davidson & CO. now owns 6,000 shares of the specialty chemicals company’s stock worth $322,000 after buying an additional 1,000 shares in the last quarter. MetLife Investment Advisors LLC boosted its holdings in HB Fuller by 5.5% during the second quarter. MetLife Investment Advisors LLC now owns 23,194 shares of the specialty chemicals company’s stock worth $1,245,000 after buying an additional 1,200 shares in the last quarter. Ronna Sue Cohen boosted its holdings in HB Fuller by 2.1% during the third quarter. Ronna Sue Cohen now owns 59,214 shares of the specialty chemicals company’s stock worth $3,060,000 after buying an additional 1,227 shares in the last quarter. Finally, OppenheimerFunds Inc. boosted its holdings in HB Fuller by 4.6% during the second quarter. OppenheimerFunds Inc. now owns 28,752 shares of the specialty chemicals company’s stock worth $1,543,000 after buying an additional 1,267 shares in the last quarter. 97.65% of the stock is currently owned by hedge funds and other institutional investors.

Shares of HB Fuller stock opened at $44.46 on Thursday. The company has a current ratio of 2.25, a quick ratio of 1.48 and a debt-to-equity ratio of 2.03. HB Fuller has a 12-month low of $41.26 and a 12-month high of $59.58. The company has a market cap of $2.20 billion, a price-to-earnings ratio of 17.78, a P/E/G ratio of 0.73 and a beta of 1.42.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 1st. Stockholders of record on Thursday, October 18th will be issued a $0.155 dividend. This represents a $0.62 annualized dividend and a dividend yield of 1.39%. The ex-dividend date of this dividend is Wednesday, October 17th. HB Fuller’s dividend payout ratio (DPR) is currently 24.80%.

HB Fuller Company Profile

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, and other specialty chemical products worldwide. The company operates through six segments: Americas Adhesives; EIMEA (Europe, India, Middle East and Africa); Asia Pacific; Construction Products; Engineering Adhesives; and Royal Adhesives.

Read More: What are Closed-End Mutual Funds?

Get a free copy of the Zacks research report on HB Fuller (FUL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HB Fuller (NYSE:FUL)

Receive News & Ratings for HB Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HB Fuller and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply